This page provides an independent statistical analysis and educational interpretation of publicly reported results. ClinicalTrials.gov provides the official trial registry record.
1. Trial at a Glance
FACTT was a completed phase 3 treatment trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI). The registry identifies the study as a factorial design evaluating procedures and fluid management approaches in acute respiratory distress syndrome and lung diseases.
Trial phase
Design model
Primary completion date
Lead sponsor
| Feature | FACTT |
|---|---|
| Condition | Acute Respiratory Distress Syndrome; Lung Diseases |
| Primary purpose | TREATMENT |
| Design | FACTORIAL |
| Interventions | Pulmonary artery catheter (procedure); central venous catheter (procedure); fluid management (procedure) |
| Status | COMPLETED |
2. Clinical Question
Population
Patients with acute respiratory distress syndrome and related lung diseases as described in the registry.
Intervention
Fluid management and catheter-based procedural strategies evaluated within the factorial design.
Comparator
Alternative randomized study strategies within the trial design.
Primary question
How do the evaluated treatment strategies affect clinically relevant outcomes in ARDS?
3. Trial Design
The ClinicalTrials.gov record identifies FACTT as a phase 3 factorial trial. A factorial design allows investigators to evaluate more than one intervention dimension within the same overall study framework, provided the design assumptions are appropriate.
Factorial design concept
In a factorial trial, participants are assigned according to combinations of interventions. The statistical analysis must account for the structure of the design and the possibility that effects of one intervention may depend on another intervention.
4. Endpoints
The ClinicalTrials.gov record does not report registered primary endpoints for this record.
No results have been posted on ClinicalTrials.gov for the registered endpoints. For factorial randomized trials, analysis would typically compare randomized groups according to the prespecified factorial structure, estimating treatment effects while preserving the benefits of randomization.
5. Statistical Methodology
Randomization and factorial analysis
Randomization is the foundation of the treatment comparison because it balances measured and unmeasured factors on average between assigned groups. In a factorial design, the statistical model must reflect the multiple intervention comparisons created by the design.
Interaction testing
A key statistical question in factorial trials is whether the effect of one intervention differs depending on assignment to another intervention. This is assessed through interaction terms in an appropriate statistical model.
General factorial model
Outcome = intervention A effect + intervention B effect + A×B interaction + error
6. Statistical Methods Explained
Why use a factorial design?
A factorial design can evaluate multiple interventions efficiently because participants contribute information to more than one comparison.
Why is interaction testing important?
If two interventions influence each other, the average effect of one intervention may not describe its effect under every combination of assignments.
Why does randomization matter?
Randomization supports unbiased comparison between treatment groups by reducing systematic differences created before treatment begins.
Why are missing data important?
Clinical trials commonly require prespecified approaches for incomplete observations because missing outcomes can affect interpretation if related to prognosis or treatment response.
7. Results
No statistical analyses or results have been posted on ClinicalTrials.gov for this registry record.
8. Limitations
- The registry does not report endpoint definitions or posted statistical analyses for this record.
- Results, effect estimates, confidence intervals, and p-values are not available in the ClinicalTrials.gov record.
- Interpretation of factorial trials requires knowledge of the prespecified analysis plan, including interaction assumptions and endpoint hierarchy.
9. Why This Trial Matters Statistically
| Concept | How it appears in FACTT |
|---|---|
| Factorial design | The registry identifies the study design model as FACTORIAL. |
| Randomization | Factorial treatment comparisons rely on randomized allocation. |
| Interaction testing | Important for determining whether intervention effects depend on another intervention. |
| Clinical trial methodology | Demonstrates analysis considerations for complex randomized designs. |
10. Related Tutorials
Learn more about the methods used in this trial:
11. Related Calculators
12. Sources
- ClinicalTrials.gov record: NCT00281268
- PubMed: PubMed record
- PubMed: PubMed record
- PubMed: PubMed record
- PubMed: PubMed record